Dr. James N. Weinstein will retire as CEO and President of Dartmouth-Hitchcock on June 30, 2017.
Dr. Jim Weinstein, CEO, moderated a conversation with Dean Kamen, DEKA Research and Development CEO, and Martine Rothblatt, United Therapeutics CEO, for the 2016 Granquist Health Policy Grand Rounds.
Dr. Jim Weinstein, CEO and president, shares the leadership role that D-H is taking to help to solve the problems faced by the nation's health care system.
John Birkmeyer, MD, executive vice president, Integrated Delivery System and chief academic officer, was interviewed on NPR about low-volume surgery restrictions for 10 complex procedures.
D-H CEO and President Dr. Jim Weinstein was among 90 honorees who received the 29th annual Ellis Island Medal of Honor from the National Ethnic Coalition of Organizations (NECO) on May 9.
Who will speak for you when you are unable to speak for yourself? On my mind this week is the need to raise awareness about the importance of communicating and documenting health care decisions.